Article

Telemedicine: well-established in ROP

The value of telemedicine in patients with retinopathy of prematurity (ROP) is well established, according to Birgit Lorenz, MD, Pediatric Department of Ophthalmology, University of Regensburg, Germany. The technology provides opportunities for research, allows expert discussion by specialists worldwide, and allows objective evaluation of the pathology.

The value of telemedicine in patients with retinopathy of prematurity (ROP) is well established, according to Birgit Lorenz,MD, Pediatric Department of Ophthalmology, University of Regensburg, Germany. The technology provides opportunities forresearch, allows expert discussion by specialists worldwide, and allows objective evaluation of the pathology.

Since the introduction of telemedicine for ROP in 2001, the technology has been useful in clinical settings where limitedresources exist for examinations by specialists, and it allows an equal chance for all premature babies, according to Dr.Lorenz.

Dr. Lorenz reported that in a study that she and her colleagues conducted, imaging showed 100% sensitivity for detectingreferral-warranted ROP.

When the results from two physicians were compared between ophthalmoscopy and imaging performed 4 months later, the agreementwas very high. Any discrepancies that occurred were not the result of missed cases of ROP, but rather because ophthalmoscopyproduced false negatives, she explained.

Interobserver variability is a challenge. For example, in a study that included 22 physicians, 70% diagnosed plus diseasewhile 30% diagnosed pre-plus disease.

The technology has limitations, according to Dr. Lorenz, such as image quality; no stereo view; dark fundus, which is achallenge and indicates that improvements in the quality of images are desirable; and imaging nasal zone II and temporal zoneIII is difficult and additional criteria are needed as aids. Finally, the cost effectiveness of the technology is as yetundetermined.

"The value of telemedicine is well established," Dr. Lorenz said. "There are some limitations in image quality. However, anobjective evaluation of the images overrides the limitations. Imaging provides a great opportunity for research. More data oncost effectiveness are needed."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.